The role of surgery for invasive pulmonary aspergillosis in paediatric hemato-oncology patients-Can we better define it?

IF 4.1 2区 医学 Q1 DERMATOLOGY
Mycoses Pub Date : 2024-07-01 DOI:10.1111/myc.13763
Mohamed Hassan, Felicia Andresen, Uyen-Thao Le, Bernward Passlick, Severin Schmid, Alexander Puzik
{"title":"The role of surgery for invasive pulmonary aspergillosis in paediatric hemato-oncology patients-Can we better define it?","authors":"Mohamed Hassan, Felicia Andresen, Uyen-Thao Le, Bernward Passlick, Severin Schmid, Alexander Puzik","doi":"10.1111/myc.13763","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Invasive pulmonary aspergillosis (IPA) is a serious condition with high morbidity and mortality in paediatric patients with cancer, haematological diseases or immunodeficiencies with or without allogeneic haematopoietic stem cell transplantation (HSCT). The role of surgical intervention for the management of IPA has scarcely been investigated.</p><p><strong>Objectives: </strong>The aim of this study was to present a single center experience of management of IPA in paediatric patients of an oncological ward, to determine the short and long-term outcomes after thoracic surgical interventions, and to outline the indications of surgical interventions in selected patients.</p><p><strong>Patients/methods: </strong>We conducted a retrospective study of 44 paediatric patients with proven and probable IPA treated in our institution between January 2003 and December 2021. The primary endpoint was the overall survival after surgical interventions. Secondary endpoints included post-operative morbidity and mortality.</p><p><strong>Results: </strong>The median age at diagnosis of IPA in our cohort was 11.79 years (range 0.11-19.6). The underlying conditions were malignancies in 34 (77%) patients and haematological or immunological disorders with allogeneic HSCT in 9 (23%) patients. We performed thoracic surgical interventions in 10 (22.7%) patients. Most patients received a video assisted thoracic surgery. Only one patient died within 90 days after surgery with a median follow-up time of 50 months. No other major post-operative complications occurred. The calculated 5-year survival rate from IPA for patients after surgical intervention with curative intention was 57% and 56% for patients without (p = .8216).</p><p><strong>Conclusions: </strong>IPA resulted in relevant morbidity and mortality in our paediatric patient cohort. Thoracic surgical interventions are feasible and may be associated with prolonged survival as a part of multidisciplinary approach in selected paediatric patients with IPA. Larger scale studies are necessary to investigate the variables associated with the necessity of surgery.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 7","pages":"e13763"},"PeriodicalIF":4.1000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycoses","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/myc.13763","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Invasive pulmonary aspergillosis (IPA) is a serious condition with high morbidity and mortality in paediatric patients with cancer, haematological diseases or immunodeficiencies with or without allogeneic haematopoietic stem cell transplantation (HSCT). The role of surgical intervention for the management of IPA has scarcely been investigated.

Objectives: The aim of this study was to present a single center experience of management of IPA in paediatric patients of an oncological ward, to determine the short and long-term outcomes after thoracic surgical interventions, and to outline the indications of surgical interventions in selected patients.

Patients/methods: We conducted a retrospective study of 44 paediatric patients with proven and probable IPA treated in our institution between January 2003 and December 2021. The primary endpoint was the overall survival after surgical interventions. Secondary endpoints included post-operative morbidity and mortality.

Results: The median age at diagnosis of IPA in our cohort was 11.79 years (range 0.11-19.6). The underlying conditions were malignancies in 34 (77%) patients and haematological or immunological disorders with allogeneic HSCT in 9 (23%) patients. We performed thoracic surgical interventions in 10 (22.7%) patients. Most patients received a video assisted thoracic surgery. Only one patient died within 90 days after surgery with a median follow-up time of 50 months. No other major post-operative complications occurred. The calculated 5-year survival rate from IPA for patients after surgical intervention with curative intention was 57% and 56% for patients without (p = .8216).

Conclusions: IPA resulted in relevant morbidity and mortality in our paediatric patient cohort. Thoracic surgical interventions are feasible and may be associated with prolonged survival as a part of multidisciplinary approach in selected paediatric patients with IPA. Larger scale studies are necessary to investigate the variables associated with the necessity of surgery.

手术治疗儿童血液肿瘤患者侵袭性肺曲霉菌病的作用--我们能否更好地定义它?
背景:侵袭性肺曲霉菌病(IPA)是一种严重的疾病,在患有癌症、血液病或免疫缺陷的儿科患者中,无论是否接受异基因造血干细胞移植(HSCT),其发病率和死亡率都很高。手术干预在治疗 IPA 中的作用还鲜有研究:本研究旨在介绍肿瘤病房儿科患者IPA的单中心治疗经验,确定胸部手术干预后的短期和长期疗效,并概述选定患者的手术干预适应症:我们对 2003 年 1 月至 2021 年 12 月期间在我院接受治疗的 44 名已证实和可能患有 IPA 的儿科患者进行了回顾性研究。主要终点是手术治疗后的总生存率。次要终点包括术后发病率和死亡率:我们队列中确诊IPA的中位年龄为11.79岁(0.11-19.6岁)。34名患者(77%)的基础疾病为恶性肿瘤,9名患者(23%)的基础疾病为血液或免疫疾病,并进行了异基因造血干细胞移植。我们对 10 例(22.7%)患者进行了胸外科干预。大多数患者接受了视频辅助胸腔手术。只有一名患者在术后 90 天内死亡,中位随访时间为 50 个月。术后未发生其他重大并发症。经计算,接受治愈性手术干预的患者从IPA获得的5年生存率为57%,未接受治愈性手术干预的患者为56%(P = .8216):结论:在我们的儿科患者队列中,IPA导致了相关的发病率和死亡率。作为多学科方法的一部分,胸外科干预是可行的,并可能延长部分IPA儿科患者的生存期。有必要进行更大规模的研究,以调查与手术必要性相关的变量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Mycoses
Mycoses 医学-皮肤病学
CiteScore
10.00
自引率
8.20%
发文量
143
审稿时长
6-12 weeks
期刊介绍: The journal Mycoses provides an international forum for original papers in English on the pathogenesis, diagnosis, therapy, prophylaxis, and epidemiology of fungal infectious diseases in humans as well as on the biology of pathogenic fungi. Medical mycology as part of medical microbiology is advancing rapidly. Effective therapeutic strategies are already available in chemotherapy and are being further developed. Their application requires reliable laboratory diagnostic techniques, which, in turn, result from mycological basic research. Opportunistic mycoses vary greatly in their clinical and pathological symptoms, because the underlying disease of a patient at risk decisively determines their symptomatology and progress. The journal Mycoses is therefore of interest to scientists in fundamental mycological research, mycological laboratory diagnosticians and clinicians interested in fungal infections.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信